Listed equity
Ajanta Pharma
अजंता फर्मा · અજંતા ફાર્મા
EOD close · 1 Sept 2026
Above 50- and 200-day MAs with +19.4% over 3 months — established uptrend.
Now at 77% of its 52-week range
Last 30 sessions
+1.0%Phase indicator
Above 50- and 200-day MAs with +19.4% over 3 months — established uptrend.
Delivery conviction
Lifetime story
Ajanta Pharma is up 184197.9% from its lifetime low of ₹1.88 on 1 Apr 2003. ₹10,000 invested then would be worth ₹1,84,29,787 today (37.9% CAGR over 23.4 years). Lifetime high of ₹3796.95 was set on 18 Aug 2026 (currently -8.7% below).
30-day conviction trend
Fundamentals
Standalone vs consolidated — most retail products show only one. Consolidated includes subsidiary contribution.
| Standalone | Consolidated | |
|---|---|---|
| P/E (TTM) | 43.48 | 38.60 |
| P/B | 9.66 | 9.02 |
| Price / Cash flow | 37.24 | 33.48 |
| Dividend yield | 0.80% | 0.80% |
| Book value / share | 363.23 ₹ | 389.03 ₹ |
| EPS (TTM) | 80.61 ₹ | 90.82 ₹ |
Returns ladder
How this page is produced
Every figure above is computed from end-of-day exchange prices, snapshotted daily, closing 1 Sept 2026. Nothing here is copied from a factsheet or a third-party summary. The full method is published, including its limitations.
Written and maintained by Azad Mohammed, who built the pipeline these numbers come out of. Found an error? Tell us — corrections are made and the page rebuilds within the hour.
This page describes what has already happened. It is not investment advice and not a recommendation to buy or sell any security. Arthkar is not a SEBI-registered investment adviser or research analyst, and does not provide or arrange investment advice. Investments in securities are subject to market risk.